These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Isolation of human pluripotent mesenchymal stem cells from second-trimester amniotic fluid using two kinds of culture protocol and their differentiation into neuron-like cells]. Feng JX, La XL, Ma Y, Bi XJ, Wen H. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Dec; 21(12):729-33. PubMed ID: 20042139 [Abstract] [Full Text] [Related]
24. Differentiation of mesenchymal stem cells from human amniotic fluid to vascular endothelial cells. Tancharoen W, Aungsuchawan S, Pothacharoen P, Markmee R, Narakornsak S, Kieodee J, Boonma N, Tasuya W. Acta Histochem; 2017 Mar; 119(2):113-121. PubMed ID: 28017358 [Abstract] [Full Text] [Related]
25. Upregulation of Nanog and Sox-2 genes following ectopic expression of Oct-4 in amniotic fluid mesenchymal stem cells. Wang KH, Kao AP, Chang CC, Lin TC, Kuo TC. Biotechnol Appl Biochem; 2015 Mar; 62(5):591-7. PubMed ID: 25385323 [Abstract] [Full Text] [Related]
26. Isolation and characterization of mesenchymal stem cells from human amniotic membrane. Díaz-Prado S, Muiños-López E, Hermida-Gómez T, Rendal-Vázquez ME, Fuentes-Boquete I, de Toro FJ, Blanco FJ. Tissue Eng Part C Methods; 2011 Jan; 17(1):49-59. PubMed ID: 20673138 [Abstract] [Full Text] [Related]
27. Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem/stromal cells. Beane OS, Fonseca VC, Cooper LL, Koren G, Darling EM. PLoS One; 2014 Jan; 9(12):e115963. PubMed ID: 25541697 [Abstract] [Full Text] [Related]
28. Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells. Lovati AB, Corradetti B, Lange Consiglio A, Recordati C, Bonacina E, Bizzaro D, Cremonesi F. Vet Res Commun; 2011 Feb; 35(2):103-21. PubMed ID: 21193959 [Abstract] [Full Text] [Related]
29. Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid. Joerger-Messerli MS, Marx C, Oppliger B, Mueller M, Surbek DV, Schoeberlein A. Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():30-44. PubMed ID: 26482184 [Abstract] [Full Text] [Related]
30. Potential role of culture mediums for successful isolation and neuronal differentiation of amniotic fluid stem cells. Orciani M, Emanuelli M, Martino C, Pugnaloni A, Tranquilli AL, Di Primio R. Int J Immunopathol Pharmacol; 2008 Feb; 21(3):595-602. PubMed ID: 18831926 [Abstract] [Full Text] [Related]
31. Epigenetic alterations in amniotic fluid mesenchymal stem cells derived from normal and fetus-affected gestations: A focus on myogenic and neural differentiations. Gasiūnienė M, Zentelytė A, Treigytė G, Baronaitė S, Savickienė J, Utkus A, Navakauskienė R. Cell Biol Int; 2019 Mar; 43(3):299-312. PubMed ID: 30635962 [Abstract] [Full Text] [Related]
32. Stem Cells Derived from Amniotic Fluid: A Potential Pluripotent-Like Cell Source for Cellular Therapy? Ramasamy TS, Velaithan V, Yeow Y, Sarkar FH. Curr Stem Cell Res Ther; 2018 Mar; 13(4):252-264. PubMed ID: 29336267 [Abstract] [Full Text] [Related]
33. Generation, Characterization, and Multilineage Potency of Mesenchymal-Like Progenitors Derived from Equine Induced Pluripotent Stem Cells. Lepage SI, Nagy K, Sung HK, Kandel RA, Nagy A, Koch TG. Stem Cells Dev; 2016 Jan 01; 25(1):80-9. PubMed ID: 26414480 [Abstract] [Full Text] [Related]
34. Large-scale expansion of pre-isolated bone marrow mesenchymal stromal cells in serum-free conditions. Gottipamula S, Muttigi MS, Chaansa S, Ashwin KM, Priya N, Kolkundkar U, SundarRaj S, Majumdar AS, Seetharam RN. J Tissue Eng Regen Med; 2016 Feb 01; 10(2):108-19. PubMed ID: 23495227 [Abstract] [Full Text] [Related]
35. The effect of meconium exposure on the expression and differentiation of amniotic fluid mesenchymal stem cells. Jensen TJ, Shui JE, Finck CM. J Neonatal Perinatal Med; 2017 Feb 01; 10(3):313-323. PubMed ID: 28854517 [Abstract] [Full Text] [Related]
36. Different culture method changing CD105 expression in amniotic fluid MSCs without affecting differentiation ability or immune function. Wang D, Liu N, Xie Y, Song B, Kong S, Sun X. J Cell Mol Med; 2020 Apr 01; 24(7):4212-4222. PubMed ID: 32119193 [Abstract] [Full Text] [Related]
37. Routine clonal expansion of mesenchymal stem cells derived from amniotic fluid for perinatal applications. Zia S, Toelen J, Mori da Cunha M, Dekoninck P, de Coppi P, Deprest J. Prenat Diagn; 2013 Oct 01; 33(10):921-8. PubMed ID: 23703584 [Abstract] [Full Text] [Related]
38. Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells. Alcayaga-Miranda F, Cuenca J, Luz-Crawford P, Aguila-Díaz C, Fernandez A, Figueroa FE, Khoury M. Stem Cell Res Ther; 2015 Mar 17; 6(1):32. PubMed ID: 25889741 [Abstract] [Full Text] [Related]
39. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage. Sridhar A, Ohlemacher SK, Langer KB, Meyer JS. Stem Cells Transl Med; 2016 Apr 17; 5(4):417-26. PubMed ID: 26933039 [Abstract] [Full Text] [Related]
40. Characterization, GFP gene Nucleofection, and allotransplantation in injured tendons of ovine amniotic fluid-derived stem cells. Colosimo A, Curini V, Russo V, Mauro A, Bernabò N, Marchisio M, Alfonsi M, Muttini A, Mattioli M, Barboni B. Cell Transplant; 2013 Apr 17; 22(1):99-117. PubMed ID: 22507078 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]